13F filer · CIK 19617 ↗
Jpmorgan Chase & Co
You are looking at Q3 2023. See the latest, Q2 2026 →
Reported value
$906.36B
−1.5% on the quarter before
Positions
7,451
1,158 new · 592 sold out
Top 10
19.3%
of the value
Est. gain
−$28.10B
on stocks held all quarter
Est. return
−3.4%
on those stocks since Q2 2023
Positions as of Sep 30, 2023, from Jpmorgan Chase & Co's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 30% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2023. Striped tiles are options.
Largest buys
Since Q2 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares Core S&P 500 ETF~$3.57BAdded · 0.5% → 0.8%+8,316,251 shares
- Amazon~$2.84BAdded · 1.9% → 2.2%+22,322,456 shares
- Ishares Core S&P Midcap ETF~$2.47BAdded · 0.2% → 0.5%+9,906,690 shares
- Mastercard~$1.44BAdded · 0.9% → 1.1%+3,649,776 shares
- Meta~$1.31BAdded · 1.4% → 1.6%+4,351,439 shares
- Alphabet~$1.28BAdded · 1.1% → 1.4%+9,703,425 shares
- Microsoft~$1.13BAdded · 4.2% → 4.1%+3,578,837 shares
- Invesco Qqq TrCALL~$1.10BAdded · 0.2% → 0.3%+3,071,600 underlying
- Kenvue Inc~$1.08BAdded · 0.0% → 0.1%+53,710,705 shares
- Broadcom~$936.2MAdded · 0.3% → 0.4%+1,127,205 shares
Largest sells
Since Q2 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF Trust~$4.44BCut · 2.9% → 2.3%−10,388,306 shares
- Apple~$3.14BCut · 3.2% → 2.5%−18,356,407 shares
- Invesco Qqq Trust Series 1~$1.87BCut · 0.4% → 0.2%−5,215,555 shares
- Jpmorgan Betabuilders Europe E~$1.84BCut · 0.7% → 0.5%−36,206,477 shares
- Vanguard S&P 500 ETF~$1.57BCut · 1.0% → 0.8%−4,009,780 shares
- SPDR S&P 500 ETF TrCALL~$764.5MCut · 0.2% → 0.1%−1,788,300 underlying
- Invesco Qqq TrPUT~$751.0MCut · 0.5% → 0.4%−2,096,100 underlying
- Dexcom Inc~$677.6MCut · 0.2% → 0.1%−7,262,910 shares
- Ishares Us Treasury Bond ETF~$675.9MCut · 0.2% → 0.2%−30,665,728 shares
- Hdfc Bank Ltd~$545.2MCut · 0.2% → 0.1%−9,239,709 shares
Holdings
As of Sep 30, 2023. Changes are in shares against Jun 30, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOMMON · shares +3.2% · price −7.3% | 4.1% | $36.82B | −$2.80B | ||||||||
| AppleCOM · shares −12% · price −11.7% | 2.5% | $22.57B | −$3.00B | ||||||||
| SPDR S&P 500 ETF TrustFUND · shares −17% · price −3.6% | 2.3% | $21.07B | −$778.6M | ||||||||
| AmazonCOMMON · shares +17% · price −2.5% | 2.2% | $19.97B | −$436.8M | ||||||||
| NvidiaCOM · shares −2.2% · price +2.8% | 1.7% | $15.14B | +$416.6M | ||||||||
| MetaCOM · shares +9.9% · price +4.6% | 1.6% | $14.53B | +$582.7M | ||||||||
| AlphabetCOMMON · shares +11% · price +9.0% | 1.4% | $12.65B | +$938.3M | ||||||||
| Unitedhealth Group IncCOM · shares +4.1% · price +4.9% | 1.3% | $11.76B | +$527.7M | ||||||||
| Vanguard Total Intl Bond ETFFUND · shares +3.2% · price −2.1% | 1.2% | $10.46B | −$222.4M | ||||||||
| MastercardCOM · shares +17% · price +0.7% | 1.1% | $9.75B | +$54.7M | ||||||||
| Eli LillyCOM · shares +12% · price +14.5% | 0.94% | $8.49B | +$963.6M | ||||||||
| Abbvie IncCOM · shares −2.7% · price +10.6% | 0.91% | $8.23B | +$791.5M | ||||||||
| Ishares Core S&P 500 ETFFUND · shares +87% · price −3.7% | 0.85% | $7.68B | −$155.9M | ||||||||
| AlphabetCOMMON · shares +5.4% · price +9.3% | 0.82% | $7.44B | +$601.8M | ||||||||
| Vanguard Total Bond MarketFUND · shares +0.2% · price −4.0% | 0.82% | $7.39B | −$307.6M | ||||||||
| TeslaCOM · shares +10% · price −4.4% | 0.81% | $7.36B | −$308.8M | ||||||||
| Vanguard S&P 500 ETFFUND · shares −18% · price −3.6% | 0.81% | $7.31B | −$271.6M | ||||||||
| ConocophillipsCOM · shares −0.4% · price +15.6% | 0.73% | $6.63B | +$896.1M | ||||||||
| Jpmorgan Betabuilders Japan ETFFUND · shares +1.6% · price −2.5% | 0.69% | $6.26B | −$159.3M | ||||||||
| Exxon Mobil CorpCOMMON · shares −6.7% · price +9.6% | 0.68% | $6.14B | +$539.4M | ||||||||
| Regeneron PharmaceuticalsCOMMON · shares +13% · price +14.5% | 0.67% | $6.08B | +$683.3M | ||||||||
| Bristol-Myers Squibb CoCOMMON · shares −6.4% · price −9.2% | 0.62% | $5.61B | −$571.7M | ||||||||
| Nxp Semiconductors Nv COM · shares −1.7% · price −2.3% | 0.61% | $5.56B | −$132.4M | ||||||||
| Lowes Cos IncCOMMON · shares +6.6% · price −7.9% | 0.58% | $5.28B | −$425.6M | ||||||||
| Eaton Corp PlcCOM · shares +16% · price +6.1% | 0.55% | $4.97B | +$243.8M | ||||||||
| Total · 7,451 positions | 100% | $906.36B | −$28.10B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2023 to Q3 2023: 5,260 stocks held throughout, down $28.10B (−3.4%).
- Eli Lilly+$963.6M+15%
- Alphabet+$938.3M+9%
- Conocophillips+$896.1M+16%
- Abbvie Inc+$791.5M+11%
- Regeneron Pharmaceuticals+$683.3M+15%
- SPDR S&P 500 ETF Trust−$778.6M−4%
- Rtx Corporation−$924.1M−27%
- Nextera Energy Inc−$1.27B−23%
- Microsoft−$2.80B−7%
- Apple−$3.00B−12%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 37 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.81T+16% | SEC ↗ |
| Q1 2026 | May 13, 2026 (amended) | $1.56T−2% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $1.59T−52% | SEC ↗ |
| Q3 2025 | Nov 7, 2025 (amended) | $3.34T+118% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $1.53T+12% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.37T+2% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.34T−49% | SEC ↗ |
| Q3 2024 | Nov 8, 2024 (amended) | $2.63T+8% | SEC ↗ |
| Q2 2024 | Aug 12, 2024 (amended) | $2.44T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 (amended) | $2.37T+14% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $2.08T+130% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $906.36B−2% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $920.27B+12% | SEC ↗ |
| Q1 2023 | May 18, 2023 (amended) | $820.88B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $758.55B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $696.38B−3% | SEC ↗ |
| Q2 2022 | Aug 11, 2022 | $717.86B−14% | SEC ↗ |
| Q1 2022 | May 11, 2022 | $830.28B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 (amended) | $865.90B+7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $808.68B−4% | SEC ↗ |
| Q2 2021 | Aug 12, 2021 | $838.21B+12% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $749.21B+10% | SEC ↗ |
| Q4 2020 | Feb 19, 2021 (amended) | $680.63B+14% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 (amended) | $595.09B+15% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $518.17B+22% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $425.90B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $536.28B+7% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $502.15B−2% | SEC ↗ |
| Q2 2019 | Aug 7, 2019 | $511.43B+4% | SEC ↗ |
| Q1 2019 | May 7, 2019 | $489.55B+13% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 | $432.49B−17% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 (amended) | $522.20B+7% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $486.35B+4% | SEC ↗ |
| Q1 2018 | May 10, 2018 | $466.55B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $474.64B+5% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $453.26B+4% | SEC ↗ |
| Q2 2017 | Aug 9, 2017 | $437.53B−0% | SEC ↗ |
| Q1 2017 | May 10, 2017 | $437.58B+5% | SEC ↗ |
| Q4 2016 | Feb 6, 2017 | $416.17B+2% | SEC ↗ |
| Q3 2016 | Nov 4, 2016 | $406.33B+1% | SEC ↗ |
| Q2 2016 | Aug 8, 2016 | $401.04B+3% | SEC ↗ |
| Q1 2016 | May 10, 2016 | $390.67B | SEC ↗ |